MRX trades 13.6% below Wall Street's consensus target of $82.67.
Last 12 months price action with 12-month analyst target path
The base valuation assumes MRX achieves its forward estimates and maintains a stable P/E multiple of 12.1x. This scenario reflects the blended consensus of 7 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 3, 2026, Marex Group Limited (MRX) has a Wall Street consensus price target of $82.67, based on estimates from 7 covering analysts. With the stock currently trading at $72.75, this represents a potential upside of +13.6%. The company has a market capitalization of $5.23B.
Analyst price targets range from a low of $80.00 to a high of $90.00, representing a 12% spread in expectations. The median target of $80.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 7 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, MRX trades at a trailing P/E of 18.8x and forward P/E of 12.1x. The forward PEG ratio of 0.30 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -34.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $124.64, with bear and bull scenarios of $78.53 and $164.23 respectively. Model confidence stands at 52/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 VIRTVirtu Financial, Inc. | $5.1B | $58.79 | $63.33 | +7.7% | Hold | 8.2x | 13 |
 MKTXMarketAxess Holdings Inc. | $5.8B | $164.14 | $142.50 | -13.2% | Hold | 20.7x | 24 |
 PIPRPiper Sandler Companies | $4.7B | $65.36 | $80.00 | +22.4% | Hold | 14.1x | 11 |
 LPLALPL Financial Holdings Inc. | $25.3B | $316.44 | $397.17 | +25.5% | Buy | 13.3x | 25 |
 IBKRInteractive Brokers Group, Inc. | $39.3B | $88.30 | $108.00 | +22.3% | Buy | 32.7x | 19 |
 GSThe Goldman Sachs Group, Inc. | $278.0B | $902.56 | $1152.33 | +27.7% | Hold | 13.2x | 55 |
 MSMorgan Stanley | $300.2B | $190.31 | $235.25 | +23.6% | Buy | 14.8x | 52 |
 JEFJefferies Financial Group Inc. | $9.4B | $45.97 | $58.17 | +26.5% | Hold | 12.6x | 9 |
 SFStifel Financial Corp | $10.7B | $70.28 | $90.00 | +28.1% | Buy | 10.8x | 22 |
 HOODRobinhood Markets, Inc. | $101.4B | $112.74 | $136.32 | +20.9% | Buy | 52.1x | 26 |
Quick answers to the most common questions about buying MRX stock.
Marex Group Limited (MRX) has a consensus 12-month price target of $82.67, implying 13.6% upside from $72.75. The 7 analysts covering MRX see moderate appreciation potential.
MRX has a consensus rating of "Buy" based on 7 Wall Street analysts. The rating breakdown is predominantly bullish, with 7 Buy/Strong Buy ratings. The consensus 12-month price target of $82.67 implies 13.6% upside from current levels.
With a forward P/E of 12.0617x, MRX trades at a relatively low valuation. The consensus target of $82.67 implies 13.6% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $90 for MRX, while the most conservative target is $80. The consensus of $82.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $164 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
MRX is moderately covered, with 7 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 7 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MRX stock forecast based on 7 Wall Street analysts shows a consensus price target of $82.67, with estimates ranging from $80 (bear case) to $90 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $125, with bear/bull scenarios of $79/$164.
Our quantitative valuation model calculates MRX's fair value at $125 (base case), with a bear case of $79 and bull case of $164. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.
MRX trades at a forward P/E ratio of 12.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on MRX, with a "Buy" consensus rating and $82.67 price target (13.6% upside). 7 of 7 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MRX analyst price targets range from $80 to $90, a 12% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $82.67 consensus represents the middle ground. Our model's $79-$164 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.